EPM

Steroid Substitutes Based on Synthetic Cannabinoid Acids

Active Seed Startup Bnei Brak Founded 2017-10

Website ↗ LinkedIn

EPM develops prescription medicine derived from synthetic cannabinoid acids to address unmet patient needs. The company has created a pipeline that includes the discovery of 14 protected synthetic molecules, including eight novel structures and production process intellectual property. Currently, EPM's focus is on two main therapeutic conditions: metabolic…